Two-year follow-up of everolimus-eluting BRS vs. metallic stent - the randomised ABSORB Japan trial

Summary

Data in the world of BRS is growing and here, within the context of the ABSORB Japan trial, Y. Onuma looks at the clinical results of a comparison between two everolimus-eluting stents – one a BRS, the other metallic.

What did they find at 2-years in terms of healing or lumen area? And what was their conclusion concerning the question of stability in terms of the bioresorbable scaffold? Learn more…